Consistent with these findings, miR-21 inhibition in human melanoma cells increases expression of the PTEN target gene, leading to suppression of AKT phosphorylation and subsequently increased Bax/Bcl-2 ratio [48]. This evidence concerns the gene BCL2 and melanoma.